INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
IR

Iannone Robert

EVP, Global Head of R&D & CMOCIK 0001737329

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 6
Max Insider Score27
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$2.95M
26.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMO · Aug 31, 2026
2
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M
$100K
884 sh
Aug 27, 2026
Aug 31, 2026
traded Aug 27, 2026
+4d
SEC FORM 4

Evidence

16
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$3.78M
27.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.51M
18.2K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$2.84M
11.4K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.53M
18.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

13
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$76K
300 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
2,916 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
27.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
26.1K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

27
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$4.92M
19.6K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

23
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$2.33M
9,259 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M—
884 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

5
IR
Iannone RobertEVP, Global Head of R&D & CMO
JAZZJazz Pharmaceuticals plc
Option exercise · 10b5-1 plan
M$400K
2,916 sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence